These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12628713)

  • 1. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?
    McCullough PA
    J Am Coll Cardiol; 2003 Mar; 41(5):725-8. PubMed ID: 12628713
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors.
    Freeman RV; Mehta RH; Al Badr W; Cooper JV; Kline-Rogers E; Eagle KA
    J Am Coll Cardiol; 2003 Mar; 41(5):718-24. PubMed ID: 12628712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with acute myocardial infarction and end-stage renal disease.
    Conti CR
    J Am Coll Cardiol; 2003 Jul; 42(2):209-10. PubMed ID: 12875752
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction.
    Berger AK; Duval S; Krumholz HM
    J Am Coll Cardiol; 2003 Jul; 42(2):201-8. PubMed ID: 12875751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
    Rabelink TJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):23-6. PubMed ID: 14671033
    [No Abstract]   [Full Text] [Related]  

  • 6. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes: an alternate take from a generalist.
    Manhapra A
    J Am Coll Cardiol; 2004 Mar; 43(5):924; author reply 924-5. PubMed ID: 14998637
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease.
    McCullough PA; Verrill TA
    Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal failure--a vasculopathic state.
    Luke RG
    N Engl J Med; 1998 Sep; 339(12):841-3. PubMed ID: 9738095
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study.
    Mann JF; Lonn EM; Yi Q; Gerstein HC; Hoogwerf BJ; Pogue J; Bosch J; Dagenais GR; Yusuf S;
    Kidney Int; 2004 Apr; 65(4):1375-80. PubMed ID: 15086477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate to high intensity statin in dialysis patients after acute myocardial infarction: A national cohort study in Asia.
    Chung CM; Lin MS; Chang CH; Cheng HW; Chang ST; Wang PC; Chang HY; Lin YS
    Atherosclerosis; 2017 Dec; 267():158-166. PubMed ID: 28985950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.
    Keltai M; Tonelli M; Mann JF; Sitkei E; Lewis BS; Hawken S; Mehta SR; Yusuf S;
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):312-8. PubMed ID: 17446813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in chronic kidney disease from a cardiologist's perspective.
    McCullough PA
    Curr Opin Nephrol Hypertens; 2004 Nov; 13(6):591-600. PubMed ID: 15483448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M; Lamas GA
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease.
    Krause MW; Massing M; Kshirsagar A; Rosamond W; Simpson RJ
    Ren Fail; 2004 Nov; 26(6):715-25. PubMed ID: 15600265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving acute coronary syndrome care: the ACC/AHA guidelines and critical pathways.
    Cannon C
    J Invasive Cardiol; 2003 Mar; 15 Suppl B():22B-27B; discussion 27B-29B. PubMed ID: 12724583
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac medications and their association with cardiovascular events in incident dialysis patients: cause or effect?
    Ishani A; Herzog CA; Collins AJ; Foley RN
    Kidney Int; 2004 Mar; 65(3):1017-25. PubMed ID: 14871422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes after percutaneous coronary revascularization with stents in patients with and without mild chronic renal insufficiency.
    Gruberg L; Weissman NJ; Waksman R; Laird JR; Pinnow EE; Wu H; Deible R; Kent KM; Pichard AD; Satler LF; Lindsay J
    Am J Cardiol; 2002 Jan; 89(1):54-7. PubMed ID: 11779523
    [No Abstract]   [Full Text] [Related]  

  • 18. Albuminuria and cardiovascular risk.
    Bogojevic Z; Bakris GL
    Heart Fail Clin; 2006 Jan; 2(1):53-9. PubMed ID: 17386876
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenges in taking care of patients on chronic haemodialysis.
    Ghosh AK
    Nephrol Dial Transplant; 2003 Jul; 18(7):1412; author reply 1412-3. PubMed ID: 12808185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Chronic renal failure in acute coronary syndromes].
    De Servi S; Guastoni C; Mariani M; Poli A; D'Urbano M; Poletti F; Seveso G
    G Ital Cardiol (Rome); 2006 Apr; 7(4 Suppl 1):30S-35S. PubMed ID: 16749289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.